Category: Drugs (A – Z)

DMARDs (Disease-modifying antirheumatic drugs ) is a category of otherwise unrelated drugs defined by their use in rheumatoid arthritis to slow down disease progression. The term is...

Frovatriptan is a triptan drug Serotonin-1b and Serotonin-1d Receptor Agonist for the treatment of migraine headaches, in particular, those associated with menstruation. The product is...

Eletriptan is a Serotonin-1b and Serotonin-1d Receptor Agonist. The mechanism of action of eletriptan is as a Serotonin 1b Receptor Agonist, and Serotonin 1d Receptor Agonist. Eletriptan is only found in...

Almotriptan is a sulfonamide triptan with extracerebral, intracranial vasoconstrictor activity. Almotriptan selectively binds to and activates serotonin 5-HT 1B and 1D receptors in the central nervous system (CNS), thereby causing...

Antimigraine drugs are the groups of drug that are used for treatment or prevention of a migraine. A migraine is a primary headache disorder characterized by recurrent headaches that...

Vonoprazan is a potassium-competitive acid blocker (PCAB) that inhibits H+, K+-ATPase-mediated gastric acid secretion. PCBs represent an alternative to proton-pump inhibitors for the treatment of...

Soraprazan is a potent and reversible inhibitor of the gastric H+/K+ ATPase proton pump with potassium-competitive acid blocking (P-CAB) activity. Soraprazan binds very specifically, competitively and reversibly to...

Revaprazan Hydrochloride is the hydrochloride salt form of a lipophilic, weak base with potassium-competitive acid blocking (P-CAB) activity. It is a drug that reduces gastric...

Linaprazan is a lipophilic, weak base with potassium-competitive acid blocking (P-CAB) activity. Linaprazan concentrates highly in the gastric parietal cell canaliculus and on entering this acidic environment is...

Azeloprazole is a drug under investigation for acid-related medical conditions responsive to suppressing the production of stomach acid. It is considered to be a member...

Lavoltidine is a highly potent and selective H2receptor antagonist which was under development & used as a treatment for gastroesophageal reflux disease but was discontinued due to the discovery that it produced gastric carcinoid...

Roxatidine is a specific and competitive histamine H2 receptor antagonist drug that is used to treat gastric ulcers, Zollinger–Ellison syndrome, erosive esophagitis, gastro-oesophageal reflux disease, and gastritis. Pharmacodynamic studies showed that 150 mg of roxatidine...

Famotidine is a propanimidamide and histamine H2-receptor antagonist with antacid activity. As a competitive inhibitor of histamine H2-receptors located on the basolateral membrane of the parietal cell, famotidine reduces basal and nocturnal gastric...